Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Liquid Biopsy as a Biomarker in Patients Treated With PSMA Radioligand Therapy

NCT07118436 is registered in ClinicalTrials.gov with Wuerzburg University Hospital as lead sponsor.

NCT NCT07118436
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07118436 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Liquid Biopsy as a Biomarker in Patients Treated With PSMA Radioligand Therapy
Lead sponsor
Wuerzburg University Hospital
Phase
Observational
Overall status
Recruiting
Start date
September 1, 2024
Completion date
August 31, 2028
Enrollment
100 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer, prostate cancer metastatic castration-resistant